Adjunctive carbamazepine + antipsychotics vs placebo/no adjunctive treatment + antipsychotics
Leaving the study early · patients with schizophrenia
It is very uncertain whether adjunctive carbamazepine + antipsychotics changes acceptability of treatment Leaving the study early due to any reason compared with placebo/no adjunctive treatment + antipsychotics (very low certainty).
1 finding from 1 review
- RR 0.47 [0.16, 1.35]8 studies · 182 participantsVery low